Technical Analysis for PLUR - Pluri Inc.

Grade Last Price % Change Price Change
D 4.91 -3.06% -0.16
PLUR closed up 0.2 percent on Wednesday, November 20, 2024, on 28 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish -3.06%
Calm After Storm Range Contraction -3.06%
NR7 Range Contraction -3.06%
Narrow Range Bar Range Contraction -3.06%
Wide Bands Range Expansion -3.06%
50 DMA Resistance Bearish -2.87%
20 DMA Support Bullish -2.87%
Hammer Candlestick Bullish -2.87%
Calm After Storm Range Contraction -2.87%
Doji - Bullish? Reversal -2.87%

   Recent Intraday Alerts

Alert Time
Down 3% 17 minutes ago
Fell Below Previous Day's Low 17 minutes ago
Down 2 % 17 minutes ago
Fell Below 20 DMA 17 minutes ago
Down 1% about 3 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pluri Inc. Description

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Surgery Stem Cell Cell Therapy Radiation Transplantation Inflammatory Transplantation Medicine Host Disease Acute Respiratory Distress Syndrome Covid 19 Graft Versus Host Disease Cell Therapy Products Surgical Oncology

Is PLUR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.48
52 Week Low 3.8016
Average Volume 22,984
200-Day Moving Average 5.70
50-Day Moving Average 5.09
20-Day Moving Average 4.90
10-Day Moving Average 5.17
Average True Range 0.43
RSI (14) 50.50
ADX 15.94
+DI 21.54
-DI 22.60
Chandelier Exit (Long, 3 ATRs) 4.85
Chandelier Exit (Short, 3 ATRs) 5.56
Upper Bollinger Bands 5.78
Lower Bollinger Band 4.03
Percent B (%b) 0.59
BandWidth 35.63
MACD Line 0.07
MACD Signal Line 0.04
MACD Histogram 0.0386
Fundamentals Value
Market Cap 209.89 Million
Num Shares 41.5 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -7.13
Price-to-Sales 127.00
Price-to-Book 3.62
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.37
Resistance 3 (R3) 5.38 5.28 5.32
Resistance 2 (R2) 5.28 5.20 5.28 5.30
Resistance 1 (R1) 5.17 5.15 5.23 5.16 5.28
Pivot Point 5.08 5.08 5.10 5.07 5.08
Support 1 (S1) 4.96 5.00 5.02 4.96 4.84
Support 2 (S2) 4.87 4.95 4.87 4.82
Support 3 (S3) 4.76 4.87 4.80
Support 4 (S4) 4.75